Stock Events

Stock Events

Search...

Frelii

$0

4

+$0+0% Thursday 20:00

Statistics

Day High

0

Day Low

0

52W High

0

52W Low

0

Volume

7,603

Avg. Volume

348

Mkt Cap

5,346.8

P/E Ratio

-

Dividend Yield

-

Dividend

-

Earnings

14NovExpected

Q1 2018

Q1 2018

Q2 2018

Q3 2018

Q1 2019

Q2 2019

Q3 2019

-0.06

-0.04

-0.03

-0.01

Expected EPS

N/A

Actual EPS

-0.06

Financials

-15,416.67%Profit Margin

Unprofitable

2013

2014

2015

2016

2017

2018

72,000Revenue

-11.1MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow FRLI. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Illumina provides sequencing and array-based solutions for genetic analysis, directly competing with Frelii's genomics-based technology.

Pacific Biosciences of California

Pacific Biosciences offers long-read sequencing technologies, competing in the genomic analysis space similar to Frelii.

Guardant Health

Guardant Health focuses on liquid biopsies and cancer diagnostics through genomic insights, competing in the personalized medicine space with Frelii.

Fulgent Genetics

Fulgent Genetics provides comprehensive genetic testing, directly competing with Frelii in the genomics-based health solutions market.

Qiagen offers sample to insight solutions including molecular diagnostics and genomic services, competing in the same space as Frelii.

Thermo Fisher Scientific

Thermo Fisher Scientific offers a wide range of services in the genetic analysis field, including sequencing, making it a competitor.

Bionano Genomics

Bionano Genomics focuses on genomic analysis and mapping, offering competitive technologies for genetic research similar to Frelii.

Intellia Therapeutics

Intellia Therapeutics is involved in CRISPR gene editing, a cutting-edge genomic technology that competes with Frelii's offerings.

Editas Medicine

Editas Medicine works on gene editing using CRISPR, competing in the genomic medicine space by offering alternatives to traditional genetic analysis.

About

Frélii, Inc. provides personalized subscription based nutrition and wellness programs. The company offers health assessments and nutrition plans based on genetic data, physiology, environmental and lifestyle factors, and lab diagnostics through its frelii.com Web platform. Its platform also provides lab diagnostics kits, compounding pharmacy products, and nutritional and vitamin supplements. The company was formerly known as Vican Resources, Inc. and changed its name to Frélii, Inc. in March 2018. Frélii, Inc. is based in Lehi, Utah.

Show more...

CEO

Mr. Ian Geran Jenkins

Employees

10

Country

US

ISIN

US3570511010

Listings

0 Comments

Share your thoughts

FAQ

What is Frelii stock price today?▼

The current price of FRLI is $0 USD — it has increased by +0% in the past 24 hours. Watch Frelii stock price performance more closely on the chart.

What is Frelii stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange Frelii stocks are traded under the ticker FRLI.

What is Frelii market cap?▼

Today Frelii has the market capitalization of 5,346.8

What were Frelii earnings last quarter?▼

FRLI earnings for the last quarter are -0.06 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.

What is Frelii revenue for the last year?▼

Frelii revenue for the last year amounts to 72,000 USD.

What is Frelii net income for the last year?▼

FRLI net income for the last year is -11.1M USD.

How many employees does Frelii have?▼

As of April 03, 2026, the company has 10 employees.

When did Frelii complete a stock split?▼

The last stock split for Frelii was on March 08, 2017 with a ratio of 1:1000.

Where is Frelii headquartered?▼

Frelii is headquartered in Lehi, US.